GB1050756A - - Google Patents
Info
- Publication number
- GB1050756A GB1050756A GB1050756DA GB1050756A GB 1050756 A GB1050756 A GB 1050756A GB 1050756D A GB1050756D A GB 1050756DA GB 1050756 A GB1050756 A GB 1050756A
- Authority
- GB
- United Kingdom
- Prior art keywords
- emulsion
- lactalbumin
- hydrolysate
- compositions
- oil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- -1 erepsin Proteins 0.000 abstract 5
- 102000004407 Lactalbumin Human genes 0.000 abstract 3
- 108090000942 Lactalbumin Proteins 0.000 abstract 3
- 239000000839 emulsion Substances 0.000 abstract 3
- 239000000413 hydrolysate Substances 0.000 abstract 3
- 239000000203 mixture Substances 0.000 abstract 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 abstract 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 abstract 2
- 235000014113 dietary fatty acids Nutrition 0.000 abstract 2
- 229930195729 fatty acid Natural products 0.000 abstract 2
- 239000000194 fatty acid Substances 0.000 abstract 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 abstract 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 abstract 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical class OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 abstract 1
- 239000004475 Arginine Substances 0.000 abstract 1
- 108010004032 Bromelains Proteins 0.000 abstract 1
- 108090000317 Chymotrypsin Proteins 0.000 abstract 1
- LEVWYRKDKASIDU-QWWZWVQMSA-N D-cystine Chemical compound OC(=O)[C@H](N)CSSC[C@@H](N)C(O)=O LEVWYRKDKASIDU-QWWZWVQMSA-N 0.000 abstract 1
- 108090000790 Enzymes Proteins 0.000 abstract 1
- 102000004190 Enzymes Human genes 0.000 abstract 1
- 108090000270 Ficain Proteins 0.000 abstract 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 abstract 1
- 239000004471 Glycine Substances 0.000 abstract 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 abstract 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 abstract 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 abstract 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 abstract 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 abstract 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 abstract 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 abstract 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 abstract 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 abstract 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 abstract 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 abstract 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 abstract 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 abstract 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 abstract 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 abstract 1
- 239000004166 Lanolin Substances 0.000 abstract 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 abstract 1
- 239000004472 Lysine Substances 0.000 abstract 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 abstract 1
- 108010019160 Pancreatin Proteins 0.000 abstract 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 abstract 1
- 239000004365 Protease Substances 0.000 abstract 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 abstract 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 abstract 1
- 239000004473 Threonine Substances 0.000 abstract 1
- 108090000631 Trypsin Proteins 0.000 abstract 1
- 102000004142 Trypsin Human genes 0.000 abstract 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 abstract 1
- 239000006035 Tryptophane Substances 0.000 abstract 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 abstract 1
- 239000000443 aerosol Substances 0.000 abstract 1
- 229960003767 alanine Drugs 0.000 abstract 1
- 235000004279 alanine Nutrition 0.000 abstract 1
- 229910021529 ammonia Inorganic materials 0.000 abstract 1
- 230000000844 anti-bacterial effect Effects 0.000 abstract 1
- 230000000845 anti-microbial effect Effects 0.000 abstract 1
- 239000004599 antimicrobial Substances 0.000 abstract 1
- 239000003963 antioxidant agent Substances 0.000 abstract 1
- 239000008346 aqueous phase Substances 0.000 abstract 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 abstract 1
- 229960003121 arginine Drugs 0.000 abstract 1
- 235000009697 arginine Nutrition 0.000 abstract 1
- 229960005261 aspartic acid Drugs 0.000 abstract 1
- 235000003704 aspartic acid Nutrition 0.000 abstract 1
- 239000003899 bactericide agent Substances 0.000 abstract 1
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical class CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 abstract 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 abstract 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical class [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 abstract 1
- 229960000541 cetyl alcohol Drugs 0.000 abstract 1
- 229960002376 chymotrypsin Drugs 0.000 abstract 1
- 238000004040 coloring Methods 0.000 abstract 1
- 239000002285 corn oil Substances 0.000 abstract 1
- 235000005687 corn oil Nutrition 0.000 abstract 1
- 239000002537 cosmetic Substances 0.000 abstract 1
- 239000006071 cream Substances 0.000 abstract 1
- 229960003067 cystine Drugs 0.000 abstract 1
- 239000003995 emulsifying agent Substances 0.000 abstract 1
- 230000002255 enzymatic effect Effects 0.000 abstract 1
- 229940088598 enzyme Drugs 0.000 abstract 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 abstract 1
- 150000002191 fatty alcohols Chemical class 0.000 abstract 1
- POTUGHMKJGOKRI-UHFFFAOYSA-N ficin Chemical compound FI=CI=N POTUGHMKJGOKRI-UHFFFAOYSA-N 0.000 abstract 1
- 235000019836 ficin Nutrition 0.000 abstract 1
- 239000006260 foam Substances 0.000 abstract 1
- 230000002538 fungal effect Effects 0.000 abstract 1
- 239000000417 fungicide Substances 0.000 abstract 1
- 229960002989 glutamic acid Drugs 0.000 abstract 1
- 235000013922 glutamic acid Nutrition 0.000 abstract 1
- 239000004220 glutamic acid Substances 0.000 abstract 1
- 229960002449 glycine Drugs 0.000 abstract 1
- ACGUYXCXAPNIKK-UHFFFAOYSA-N hexachlorophene Chemical compound OC1=C(Cl)C=C(Cl)C(Cl)=C1CC1=C(O)C(Cl)=CC(Cl)=C1Cl ACGUYXCXAPNIKK-UHFFFAOYSA-N 0.000 abstract 1
- 229960004068 hexachlorophene Drugs 0.000 abstract 1
- 229960002885 histidine Drugs 0.000 abstract 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 abstract 1
- 230000003301 hydrolyzing effect Effects 0.000 abstract 1
- 229960000310 isoleucine Drugs 0.000 abstract 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 abstract 1
- 229940039717 lanolin Drugs 0.000 abstract 1
- 235000019388 lanolin Nutrition 0.000 abstract 1
- 229960003136 leucine Drugs 0.000 abstract 1
- 229940057995 liquid paraffin Drugs 0.000 abstract 1
- 239000006210 lotion Substances 0.000 abstract 1
- 229960003646 lysine Drugs 0.000 abstract 1
- 229930182817 methionine Natural products 0.000 abstract 1
- 229960004452 methionine Drugs 0.000 abstract 1
- 235000013336 milk Nutrition 0.000 abstract 1
- 210000004080 milk Anatomy 0.000 abstract 1
- 239000003921 oil Substances 0.000 abstract 1
- 235000019198 oils Nutrition 0.000 abstract 1
- 239000002674 ointment Substances 0.000 abstract 1
- 150000002942 palmitic acid derivatives Chemical class 0.000 abstract 1
- 229940055695 pancreatin Drugs 0.000 abstract 1
- 239000002304 perfume Substances 0.000 abstract 1
- 235000019271 petrolatum Nutrition 0.000 abstract 1
- 239000012071 phase Substances 0.000 abstract 1
- 239000000047 product Substances 0.000 abstract 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 abstract 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 abstract 1
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 abstract 1
- 235000010199 sorbic acid Nutrition 0.000 abstract 1
- 239000004334 sorbic acid Substances 0.000 abstract 1
- 229940075582 sorbic acid Drugs 0.000 abstract 1
- 239000012049 topical pharmaceutical composition Substances 0.000 abstract 1
- 239000012588 trypsin Substances 0.000 abstract 1
- 229960004799 tryptophan Drugs 0.000 abstract 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 abstract 1
- 239000004474 valine Substances 0.000 abstract 1
- 239000011782 vitamin Substances 0.000 abstract 1
- 229940088594 vitamin Drugs 0.000 abstract 1
- 229930003231 vitamin Natural products 0.000 abstract 1
- 235000013343 vitamin Nutrition 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J23/00—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00
- B01J23/70—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of the iron group metals or copper
- B01J23/89—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of the iron group metals or copper combined with noble metals
- B01J23/8913—Cobalt and noble metals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH1182564A CH428100A (fr) | 1964-09-10 | 1964-09-10 | Composition pour le traitement et les soins de la peau |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1050756A true GB1050756A (enrdf_load_stackoverflow) | 1900-01-01 |
Family
ID=4377244
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB1050756D Expired GB1050756A (enrdf_load_stackoverflow) | 1964-09-10 |
Country Status (6)
| Country | Link |
|---|---|
| BE (1) | BE669090A (enrdf_load_stackoverflow) |
| BR (1) | BR6572997D0 (enrdf_load_stackoverflow) |
| CH (1) | CH428100A (enrdf_load_stackoverflow) |
| DE (1) | DE1492149A1 (enrdf_load_stackoverflow) |
| GB (1) | GB1050756A (enrdf_load_stackoverflow) |
| IT (1) | IT961354B (enrdf_load_stackoverflow) |
Cited By (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5598110A (en) * | 1979-01-16 | 1980-07-25 | Nestle Sa | Local administration composition |
| EP0545759A1 (fr) * | 1991-11-28 | 1993-06-09 | Société BFB | Utilisation d'un acide aminé soufré, éventuellement en association avec la pyridoxine, pour la préparation d'un médicament destiné au traitement de l'eczéma |
| EP0696451A1 (en) * | 1994-08-09 | 1996-02-14 | Revlon Consumer Products Corporation | Cosmetic formulations having keratolytic and/or anti-acne activity, their preparation and use |
| EP1192940A1 (en) * | 2000-10-02 | 2002-04-03 | Johnson & Johnson Consumer Companies, Inc. | Compositions and methods for promoting clear skin using an alkanolamine |
| FR2828099A1 (fr) * | 2001-08-02 | 2003-02-07 | Soc Extraction Principes Actif | Utilisation d'un hydrolysat de proteines riche en tyrosine pour augmenter la synthese de melanine |
| WO2003013487A3 (en) * | 2001-08-08 | 2003-05-30 | Professional Dietetics Srl | Amino-acid-based compositions, suitable in therapy for the healing and/or mending of wounds and lesions, in particular for application in the ophthalmic field |
| WO2003063816A1 (en) * | 2002-01-30 | 2003-08-07 | The Procter & Gamble Company | Topical skin and/or hair compositions containing an hydrolysed protein |
| WO2003018049A3 (en) * | 2001-08-23 | 2003-11-06 | Westgate Biolog Ltd | Use of milk serum apoproteins in the prophylaxis or treatment of microbial or viral infection |
| WO2005079745A1 (en) * | 2004-02-19 | 2005-09-01 | Reckitt & Colman (Overseas) Limited | Skincare compositions comprising salicylic acid |
| US7396526B1 (en) | 1998-11-12 | 2008-07-08 | Johnson & Johnson Consumer Companies, Inc. | Skin care composition |
| US7645796B2 (en) | 2004-04-01 | 2010-01-12 | Ajinomoto Co., Inc. | Amino acid composition promoting collagen synthesis |
| US10751267B2 (en) | 2016-12-21 | 2020-08-25 | Conopco, Inc. | Personal care compositions comprising poorly soluble compounds |
| US11077039B2 (en) | 2016-12-21 | 2021-08-03 | Conopco, Inc. | Topical skin lightening additive and composition with amino acids and nicotinamide compounds |
| US11260005B2 (en) | 2016-12-21 | 2022-03-01 | Conopco, Inc. | Personal care compositions with glutathione precursor comprising 4-substituted resorcinols and amino acids |
| US11337908B2 (en) | 2016-12-21 | 2022-05-24 | Conopco, Inc. | Personal care compositions with cystine |
| US11540984B2 (en) | 2018-05-23 | 2023-01-03 | Conopco, Inc. | Nanoemulsions and a method for making the same |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9308103D0 (en) * | 1993-04-20 | 1993-06-02 | Unilever Plc | Cosmetic composition |
-
0
- GB GB1050756D patent/GB1050756A/en not_active Expired
-
1964
- 1964-09-10 CH CH1182564A patent/CH428100A/fr unknown
-
1965
- 1965-09-02 BE BE669090D patent/BE669090A/xx unknown
- 1965-09-04 IT IT982165A patent/IT961354B/it active
- 1965-09-08 DE DE19651492149 patent/DE1492149A1/de active Pending
- 1965-09-09 BR BR17299765A patent/BR6572997D0/pt unknown
Cited By (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5598110A (en) * | 1979-01-16 | 1980-07-25 | Nestle Sa | Local administration composition |
| FR2446634A1 (fr) * | 1979-01-16 | 1980-08-14 | Nestle Sa Soc Ass Tech Prod | Composition a base d'hydrolysat de lactalbumine pour le traitement et les soins de la peau |
| EP0545759A1 (fr) * | 1991-11-28 | 1993-06-09 | Société BFB | Utilisation d'un acide aminé soufré, éventuellement en association avec la pyridoxine, pour la préparation d'un médicament destiné au traitement de l'eczéma |
| EP0696451A1 (en) * | 1994-08-09 | 1996-02-14 | Revlon Consumer Products Corporation | Cosmetic formulations having keratolytic and/or anti-acne activity, their preparation and use |
| US7396526B1 (en) | 1998-11-12 | 2008-07-08 | Johnson & Johnson Consumer Companies, Inc. | Skin care composition |
| EP1192940A1 (en) * | 2000-10-02 | 2002-04-03 | Johnson & Johnson Consumer Companies, Inc. | Compositions and methods for promoting clear skin using an alkanolamine |
| FR2828099A1 (fr) * | 2001-08-02 | 2003-02-07 | Soc Extraction Principes Actif | Utilisation d'un hydrolysat de proteines riche en tyrosine pour augmenter la synthese de melanine |
| WO2003013487A3 (en) * | 2001-08-08 | 2003-05-30 | Professional Dietetics Srl | Amino-acid-based compositions, suitable in therapy for the healing and/or mending of wounds and lesions, in particular for application in the ophthalmic field |
| AU2002356112B2 (en) * | 2001-08-23 | 2007-11-08 | Westgate Biological Limited | Use of milk serum apoproteins in the prophylaxis or treatment of microbial or viral infection |
| WO2003018049A3 (en) * | 2001-08-23 | 2003-11-06 | Westgate Biolog Ltd | Use of milk serum apoproteins in the prophylaxis or treatment of microbial or viral infection |
| US7687074B2 (en) * | 2001-08-23 | 2010-03-30 | Westgate Biological Ltd. | Use of milk serum apoproteins in the treatment of microbial or viral infection |
| US7972629B2 (en) | 2001-08-23 | 2011-07-05 | Westgate Biological Ltd. | Product comprising a combination of milk serum apoproteins and free fatty acids |
| WO2003063816A1 (en) * | 2002-01-30 | 2003-08-07 | The Procter & Gamble Company | Topical skin and/or hair compositions containing an hydrolysed protein |
| WO2005079745A1 (en) * | 2004-02-19 | 2005-09-01 | Reckitt & Colman (Overseas) Limited | Skincare compositions comprising salicylic acid |
| US7645796B2 (en) | 2004-04-01 | 2010-01-12 | Ajinomoto Co., Inc. | Amino acid composition promoting collagen synthesis |
| US10751267B2 (en) | 2016-12-21 | 2020-08-25 | Conopco, Inc. | Personal care compositions comprising poorly soluble compounds |
| US10980718B2 (en) | 2016-12-21 | 2021-04-20 | Conopco, Inc. | Personal care compositions comprising poorly soluble compounds |
| US11077039B2 (en) | 2016-12-21 | 2021-08-03 | Conopco, Inc. | Topical skin lightening additive and composition with amino acids and nicotinamide compounds |
| US11260005B2 (en) | 2016-12-21 | 2022-03-01 | Conopco, Inc. | Personal care compositions with glutathione precursor comprising 4-substituted resorcinols and amino acids |
| US11337908B2 (en) | 2016-12-21 | 2022-05-24 | Conopco, Inc. | Personal care compositions with cystine |
| US11596586B2 (en) | 2016-12-21 | 2023-03-07 | Conopco, Inc. | Personal care compositions with glutathione precursor comprising 4-substituted resorcinols and amino acids |
| US11666519B2 (en) | 2016-12-21 | 2023-06-06 | Conopco, Inc. | Personal care compositions with cystine |
| US11540984B2 (en) | 2018-05-23 | 2023-01-03 | Conopco, Inc. | Nanoemulsions and a method for making the same |
Also Published As
| Publication number | Publication date |
|---|---|
| DE1492149A1 (de) | 1970-02-26 |
| CH428100A (fr) | 1967-01-15 |
| BE669090A (enrdf_load_stackoverflow) | 1966-03-02 |
| IT961354B (it) | 1973-12-10 |
| BR6572997D0 (pt) | 1973-09-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB1050756A (enrdf_load_stackoverflow) | ||
| Tripathy et al. | Synthesis, chemistry, physicochemical properties and industrial applications of amino acid surfactants: A review | |
| Agboola et al. | Enzymatic hydrolysis of milk proteins used for emulsion formation. 1. Kinetics of protein breakdown and storage stability of the emulsions | |
| US4859653A (en) | Use of compositions of matter containing N-acylates of alpha aminoacids for the treatment of skin | |
| JPH03169822A (ja) | 含水ペースト型製薬組成物 | |
| AU5897496A (en) | Pharmaceutical and/or dietetic compositions with antioxidant activity containing carnosine or derivatives and branched amino acids | |
| FR2637182A1 (fr) | Compositions a base de phases lamellaires lipidiques hydratees ou de liposomes contenant un ecdysteroide, de preference l'ecdysterone, ou l'un de ses derives; et compositions cosmetiques, pharmaceutiques, notamment dermatologiques, de sericulture ou phytosanitaires l'incorporant | |
| EP0701549A1 (fr) | Procede de preparation de melanges d'acides amines n-acyles | |
| ES2062231T5 (es) | Mezclas de proteinas, de peptidos y de aminoacidos con una composicion de aminoacidos optimizada. | |
| FR2771632A1 (fr) | Composition synergique comprenant au moins un lipoaminoacide et au moins un glycol; application en cosmetique | |
| CA1131561A (en) | Composition for topical administration | |
| US4342747A (en) | Colostrum-based composition for external use | |
| Vásquez et al. | Functional properties of rainbow trout (Oncorhynchus mykiss) viscera protein hydrolysates | |
| DE69524965D1 (de) | Wachstumshormon und valin enthaltende arzneimittel | |
| Flanagan et al. | Functionality of Bacillus proteinase hydrolysates of sodium caseinate | |
| IL30741A (en) | Oil-in-water skin care emulsion | |
| CA2131688A1 (fr) | Composition cosmetique pour le maintien de la coiffure, contenant une proteine de lait et/ou un hydrolysat de proteine de lait et un hydrolysat de keratine | |
| Ripollés et al. | Antioxidant activity of co-products from milk fat processing and their enzymatic hydrolysates obtained with different proteolytic preparations | |
| US20100062052A1 (en) | Peptide-based compounds as new inhibitors of metalloectopeptidases, compositions comprising said compounds and their pharmaceutical and cosmetic uses | |
| EP1722752B1 (en) | A cleansing composition based on oily substances | |
| GB2137495A (en) | Anti-acne composition | |
| EP0736102B1 (fr) | Procede d'obtention de produits peptidiques | |
| WO2008145854A1 (fr) | Composition pharmaceutique et/ou cosmetique contenant des peptides | |
| EP2150266A1 (fr) | Composition pharmaceutique et/ou cosmetique contenant un principe actif antioxydant et activateur de l'energie cellulaire | |
| JPS6097042A (ja) | 乳化組成物 |